UBC Community and Partners Publications

Microscopic Menace Vice President Research, Office of the 2006

You don't seem to have a PDF reader installed, try download the pdf

Item Metadata

Download

Media
Microscopic Menace[2].pdf [ 292.15kB ]
Metadata
JSON: 1.0075453.json
JSON-LD: 1.0075453+ld.json
RDF/XML (Pretty): 1.0075453.xml
RDF/JSON: 1.0075453+rdf.json
Turtle: 1.0075453+rdf-turtle.txt
N-Triples: 1.0075453+rdf-ntriples.txt
Original Record: 1.0075453 +original-record.json
Full Text
1.0075453.txt
Citation
1.0075453.ris

Full Text

K CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.13K CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by: ROS/KB/MRK CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.From ?ghting microbial infections to preparingfor pandemics,   Brett Finlay is discovering howthe body ? s own defenses could boost our chancesin the battle against infectious diseases14 December 2006K CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.K CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.?We learned with SARS, if you?re going to ?ght something, you have to have the engine running before it hits.?Black Death. Spanish Flu. Asian In?uenza. History is littered with prominent examples of devastating pandemics. Beyond their shared ability to decimate populations on a grand scale, these infectious outbreaks have also demonstrated the capacity to resurface at a curiously consistent frequency. For scientists today, the question is not a matter of if a pandemic will strike, but when.Most experts predict the Avian Flu ?   which has already killed over 140 people worldwide without mutating to a human-to-human strain ? will be the next disastrous pandemic. Whatever the strain, UBC Vancouver professor of microbiology   and immunology Dr. Brett Finlay isn?t   waiting around to ?nd out.Part of Finlay?s strategy to prepare for the next pandemic is to work on boosting the body?s innate ability to ?ght o? disease so that we are more resilient when we encounter disease in the ?rst place.?We learned with SARS, if you?re going to ?ght something, you have to have the engine running before it hits,? Finlay explains. ?That was a very valuable lesson because we realized we needed to have the capacity already built in order to address   the next threat, whatever it may be.?Instead of focusing solely on how foreign agents infect host cells, Finlay and his colleague UBC Vancouver microbiology professor Dr. Bob Hancock quickly realized a third component of the infection process was being ignored: the body?s own defense mechanisms. Although the human body regularly comes into contact with infectious agents, infection is relatively rare because the human body possesses innate defenses in the form of healthy bacteria to deal rapidly with nearly all microbial infections. In order for an infection to   occur, successful pathogen bacteria must   in?ltrate these barriers. By understanding the mechanisms with which the body Photo> Getty Images News/Paula BronsteinK CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.15K CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by: ROS/KB/MRK CY MDocket no.: 1162Version no: 1Client : UBC ResearchDate: 2006 Nov 10Item: Frontier magazineSize: 8.5x11.75 inchesLogos: reproPhotos: hiresLine Screen: 150 lineFonts:  DIN, A Garamond Pro, Avant Garde, CloisterProofed by:ROS/KB/MR  All trapping is the responsibility of the printer/pre-press company outputting ?nal ?lm/plates.protects itself, Finlay hopes to translate those ?ndings into new means to battle viral and bacterial infections.Boosting the body?s natural immunity can help more than in pandemic situations. The human tragedy in?icted by infectious diseases is felt around the world, especially in developing nations. One third of the   50 million people who die worldwide each year are due to infectious diseases. Until recently, many of these diseases were treated successfully with antibiotics. But antibiotic resistance has dramatically reduced our ability to treat disease e?ectively ? and is growing at an alarming rate. Many infectious agents that were once eliminated by antibiotics are now 20 to 40 per cent resistant to them, a shift that Finlay ?nds increasingly troubling.?We have about a 10-year window before it becomes a horrible problem,? Finlay says. ?Every year, resistance increases. Every year, there are less and less antibiotics. Pharmaceutical companies have completely pulled out of antibiotic production so we have to ?nd alternative ways to treat and control infectious diseases.?This desperate need for alternative ways to tackle infectious diseases has led Finlay to dedicate his career to understanding how microbial infections work. And his research has been more than promising. Last year, he and his team of scientists received an unprecedented $8.7-million USD grant over ?ve years as part of a $450-million pledge towards world health issues made by the Bill and Melinda Gates Foundation and the Foundation for the National Institutes of Health in the US, a competitive process that drew more than 1,500 applications worldwide. Using salmonella and a type of E.coli as models for the way bacteria behave, Finlay and his research team have set their sights on changing the way infectious diseases are treated worldwide.?When we started doing this, I had no idea it would actually end up getting anything. But I think the reputation of the scientists, the idea and the preliminary data we had all added to make a very compelling proposal,? he says.For those living in developing countries, a breakthrough in the treatment of infectious disease would bring immeasurable relief. Most lethal cases of typhoid fever, gastroenteritis, meningitis, urinary tract infection and kidney disease in these areas are a direct result of salmonella and E.coli infections. At the end of ?ve years, Finlay hopes to produce a product that has   made it through clinical trials and can be taken to the developing world for immediate treatment and prevention   of these a?ictions.?As a scientist, the capacity to actually impact immediately is extremely exciting,? Finlay acknowledges. ?The idea that I actually helped people is really rewarding   in science. I think that?s ultimately what drives us.?In addition to his work with the Bill and Melinda Gates Foundation, Finlay is continuing to pursue research on developing salmonella and E.coli vaccines for chickens and cows. His work with Genome BC also strives to identify the key hubs in pathogen bacteria to initiate the successful collapse of these organisms. Although his research spans multiple projects, Finlay ultimately sees an overlap that will help work towards a greater goal: ?My research is twofold,? he explains, ?it?s working on controlling infectious diseases in our society but I also see it as an exercise that, as an o?shoot, we can apply immediately to whatever the next threat is going to be through rapid response.?Finlay?s contributions to the ?eld of   science have not gone unrecognized in the country where his scienti?c ambitions began. In 2006, he was one of two UBC professors who received Canada?s highest honour ? the Order of Canada. Appointed as an O?cer, Finlay was recognized for   ?a lifetime of achievement and merit of a   high degree, especially in service to Canada or to humanity at large.? This recognition   is particularly special for Finlay who became the second person in his family, after his mother, to receive the title.Finlay has come a long way since spending his childhood looking down microscopes and cleaning dinosaur bones   at the University of Alberta with his   parents. Aside from potentially helping millions of people around the world,   Finlay sees educating the public about   the power of scienti?c inquiry as   another important mission he is more   than willing to champion.?The idea of hiding in your ivory tower where you don?t have the time to talk to anyone, I disagree with that completely,? he says. ?Science impacts on every aspect of our everyday lives. The more people who appreciate science and know a bit about the process, the better the world will be.?Dr. Brett Finlay receives funding   for his projects from the Canadian Institutes of Health Research (CIHR),   the Natural Sciences and Engineering   Research Council of Canada (NSERC), Howard Hughes Medical Institute,   the Michael Smith Health Research Foundation, the Canadian Association   of Gastroenterology and Genome Canada in addition to his $8.7-million USD grant from the Bill and Melinda Gates Foundation and the Foundation for the National Institutes of Health.Photos> Panos Pictures/Dieter Telemans

Cite

Citation Scheme:

    

Usage Statistics

Country Views Downloads
China 7 0
Germany 5 0
United States 4 11
Japan 2 0
Canada 2 0
Belarus 1 1
France 1 0
City Views Downloads
Beijing 7 0
Unknown 7 1
Ashburn 4 11
Ottawa 2 0
Tokyo 2 0

{[{ mDataHeader[type] }]} {[{ month[type] }]} {[{ tData[type] }]}
Download Stats

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
http://iiif.library.ubc.ca/presentation/dsp.1312.1-0075453/manifest

Comment

Related Items